Financial Times Digital Health Summit USA
Future of business interaction
A study on the interaction between MedTech companies and hospitals
With this study, we shine a spotlight on the challenges in business interactions today. We aim to drive forward the discussion among stakeholders so as to find solutions that can be applied broadly, yielding benefits for all parties involved.
EU Clinical Trial Regulation
Building a successful program
The implementation of the new European Union (EU) Clinical Trial Regulation will provide a unified portal and database for trial sponsors and regulatory agencies across the EU Member States, promising to bring greater regulatory convergence and efficiency to the clinical trial application process.
How do health care consumers and doctors see virtual care?
Our 2018 survey results show an interesting juxtaposition
Virtual health care is popular—in theory. Deloitte surveys of US physicians and health care consumers found support for the concept, but doctors aren’t meeting demand. However, organizations that get on board sooner rather than later may see the benefits.
The future awakens
Life Sciences and Health Care Predictions 2022
The year is 2022. The quantified self is alive and well, digital technologies have transformed the culture of health care and new entrants have disrupted delivery models. These are some of our predictions that, if they come true, will shake up the life sciences and health care industry.
A new future for R&D?
Measuring the return from pharmaceutical innovation 2017
Pharmaceutical innovation study by the Deloitte UK Centre for Health Solutions looks at the challenges the industry faces in generating returns from its R&D investments while highlighting the key strategies to help increase pipeline value while reduce R&D costs to generate sustainable R&D returns.
Time to care
Securing a future for the hospital workforce in Europe
In light of rising demand, staff shortages and lack of time for hands-on-care, is the current hospital workforce model sustainable? New research released by the Deloitte UK Centre for Health Solutions explores the current state of hospital workforces across Europe and their key challenges.
The digital hospital of the future
In 10 years, technology may change the face of global health care delivery
Learn how the digital hospital of the future can leverage technology to transform the future of health care delivery, including digital patient experience in this report developed by Deloitte US.
Regulation in Life Sciences
Turning complexity into opportunity
Stay ahead of the curve when it comes to regulatory policy in Life Sciences. Here you'll find a range of tools on a variety of topics from around the globe that provide critical insight and advice, helping you to anticipate change and plan ahead.
Pharma and the connected patient
How digital technology is enabling patient centricity
New research released by the Deloitte UK Centre for Health Solutions explores how digital technology can help pharma embrace patient centricity to remain relevant, profitable, and to deliver better health outcomes.
Strategies for stemming the opioid epidemic
How analytics can aid health plans and PBMs
The opioid crisis in the United States continues to reverberate across society. While a holistic solution remains elusive, health plans and pharmacy benefit managers are evolving their use of data analytics and technology to improve prevention and treatment among their members and in their communities.
Under the spotlight
Data integrity in life sciences
Regulatory bodies now have high expectations with regard to data quality and integrity owing to the life sciences industry’s growth, globalization and adoption of advanced technology, such as highly automated systems and storage of data in ‘The Cloud’. Read the report to learn more.
High-value health care
Innovative approaches to global challenges
What are pioneering health care providers, health plans, and life science companies doing to anticipate patient needs, reduce costs, and improve overall health outcomes in the US and globally? Learn more in this new Deloitte Center for Health Solutions research.
Identification of Medicinal Products
Identification of Medicinal Products (IDMP) is one the biggest regulatory challenges for all pharmaceutical companies operating in Europe. How can your organisation navigate this journey towards increased patient safety and use it as an opportunity for business transformation?